Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New drug TG02 shows promise in early brain cancer trial

NCT ID NCT03224104

First seen Dec 12, 2025 · Last updated May 17, 2026 · Updated 19 times

Summary

This early-phase study tested the drug TG02 in 71 patients with aggressive brain tumors (anaplastic astrocytoma or glioblastoma). The goal was to find the safest dose when combined with either radiation or chemotherapy. The study focused on newly diagnosed elderly patients and those whose cancer had returned, aiming to control the disease rather than cure it.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GLIOBLASTOMA are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Assistance Publique - Hopitaux de Marseille - Hôpital de La Timone

    Marseille, 13385, France

  • CHRU de Lille

    Lille, France

  • CHU de Lyon - CHU Lyon - Hopital neurologique Pierre Wertheimer

    Bron, 69677, France

  • Erasmus MC Cancer Institute - location Daniel den Hoed

    Rotterdam, 3015, Netherlands

  • Klinikum Der J.W. Goethe Universitaet-Klinik und Poliklinik fur Neurochirurgie

    Frankfurt, 60528, Germany

  • UniversitaetsSpital Zurich

    Zurich, 8091, Switzerland

  • Universitaetskliniken Regensburg - Universitaetsklinikum Regensburg

    Regensburg, 93053, Germany

  • Universitaetskliniken der Uni Wien - Universitaetsklinikum Wien - AKH uniklinieken

    Vienna, 1090, Austria

  • Universitaetsklinikum Bonn

    Bonn, 53205, Germany

  • Universitaetsklinikum Heidelberg - UniversitaetsKlinikum Heidelberg - Head Hospital

    Heidelberg, 69120, Germany

Conditions

Explore the condition pages connected to this study.